1-2 of 2
AnnaLynn M. Williams
Close
Sort by
Journal Articles

Neurocognitive impairment associated with chronic morbidity in long-term survivors of Hodgkin Lymphoma

Clinical Trials & Observations
Nicholas S. Phillips, Daniel A. Mulrooney, AnnaLynn M. Williams, Wei Liu, Raja B. Khan, Matthew J. Ehrhardt, Tim Folse, Matthew Krasin, Deo Kumar Srivastava, Kirsten K. Ness, Melissa M. Hudson, Noah D. Sabin, Kevin R. Krull
Journal: Blood Advances
Blood Adv (2023) 7 (23): 7270–7278.
https://doi.org/10.1182/bloodadvances.2023010567
Published: 2023
Includes: Supplemental data
Journal Articles

A retrospective comparison of venetoclax alone or in combination with an anti-CD20 monoclonal antibody in R/R CLL

Clinical Trials & Observations
Anthony R. Mato, Lindsey E. Roeker, Toby A. Eyre, Chadi Nabhan, Nicole Lamanna, Brian T. Hill, Danielle M. Brander, Paul M. Barr, Frederick Lansigan, Bruce D. Cheson, Arun K. Singavi, Maryam Sarraf Yazdy, Nirav N. Shah, John N. Allan, Erica B. Bhavsar, Joanna Rhodes, Kaitlin Kennard, Stephen J. Schuster, AnnaLynn M. Williams, Alan P. Skarbnik, Andre H. Goy, Julie M. Goodfriend, Colleen Dorsey, Catherine C. Coombs, Hande Tuncer, Chaitra S. Ujjani, Ryan Jacobs, Allison M. Winter, John M. Pagel, Neil Bailey, Anna Schuh, Mazyar Shadman, Andrea Sitlinger, Hanna Weissbrot, Sivraj Muralikrishnan, Andrew Zelenetz, Amy A. Kirkwood, Christopher P. Fox
Journal: Blood Advances
Blood Adv (2019) 3 (10): 1568–1573.
https://doi.org/10.1182/bloodadvances.2019000180
Published: 2019